Decades-old FDA-approved drug can slow progression of Alzheimer’s

New York Post·Feb 12

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A decades-old FDA-approved drug, typically used to treat seizures, has shown promise in slowing the progression of Alzheimer's disease. The drug appears to prevent the formation of Alzheimer's plaques and reduce amyloid buildup in the brain. Research suggests this drug may potentially prevent Alzheimer's before it begins, offering a possible breakthrough in treatment.

Full coverage

Common anti-seizure drug prevents Alzheimer’s plaques from forming

Northwestern Now News·Feb 11

Decades-old anti-seizure drug shows promise in preventing Alzheimer’s before it begins

Drug Discovery News·Feb 17

Fetching the latest headlines…

Decades-old FDA-approved drug can slow progression of Alzheimer’s

Full coverage

Common anti-seizure drug prevents Alzheimer’s plaques from forming

Decades-old anti-seizure drug shows promise in preventing Alzheimer’s before it begins

Alzheimer's: Anti-seizure drug helps reduce amyloid buildup in brain

Controversial New Alzheimer’s Drugs Offer Hope—But at a High Cost

The next big breakthroughs in Alzheimer’s science and treatment

Can we prevent Alzheimer’s disease within a decade?

Alzheimer’s prevention breakthrough found in decades-old seizure drug

FDA-Approved Seizure Drug May Stop Alzheimer’s Before It Starts